Status:
COMPLETED
Intradialytic Kinetics of Cardiac Biomarkers During Hemodialysis and Hemodiafiltration
Lead Sponsor:
Aalborg University Hospital
Conditions:
End Stage Renal Disease on Dialysis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This randomized, crossover study aims to investigate the intradialytic kinetics of selected cardiac biomarkers in patients with end-stage renal disease treated with dialysis. The cardiac biomarkers of...
Detailed Description
Patients treated with maintenance hemodialysis: Single-center, randomized, crossover study with 24 participants. The study will investigate the effect of high-flux HD (using the FX CorDiax 100 dialyz...
Eligibility Criteria
Inclusion
- Age of 18 years or older.
- Clinically stable patients with end-stage renal disease treated with maintenance hemodialysis or peritoneal dialysis.
- Regarding patients treated with hemodialysis: Dialysis access with an arteriovenous fistula and able to maintain a blood flow rate \>300 mL.
Exclusion
- \- Not able to understand or sign informed consent.
Key Trial Info
Start Date :
September 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 10 2025
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT06526702
Start Date
September 12 2024
End Date
April 10 2025
Last Update
October 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nephrology, Aalborg University Hospital
Aalborg, Denmark, 9000